Post-doctoral fellow, NMR spectroscopy / structural chemistry - 138/01
You will apply NMR methods to study the interation between the ligand
binding domains of nuclear hormone receptors and drug scaffolds. Working
closely with computational chemists, synthetic organic chemists and
bioscientists you will be involved in the discovery of novel chemical lead
molecules that perturbe the function of these receptors. In addition you
will study the interaction of nuclear receptors with other proteins of high
biological importance. You need to have a solid background in NMR and be
enthusiastic to work in a team of six protein NMR spectroscopists.
Experience with protein chemistry or organic chemistry would be an
advantage. The position is for 3 years.
For further information, please contact Rutger Folmer, phone +46 31 776 20
43, rutger.folmer@astrazeneca.com, or Karl Hard, +46 31 776 1604,
karl.hard@astrazeneca.com
Please send your application, marked "138/01 post-doc" no later than May 31
to: AstraZeneca R&D Mölndal, Human Resources, Victoria Persson, SE-431 83
Mölndal, Sweden.
The position is part of a recently initiated company-wide Nuclear Hormone
Receptor program:
AstraZeneca has a strong track record in drug discovery programmes which
target Nuclear Hormone Receptors. We are now intending to expand our
research activities within this field. To this end we are looking for six
experienced scientists to take up Post Doctoral positions at the Mölndal
site near Gothenburg, Sweden as part of a global program involving
researchers based in the Sweden, the UK, and the US.
You will work as part of an inter-disciplinary team of molecular and cell
biologists, biochemists, pharmacologists, structural, computational and
medicinal chemists aimed at developing novel therapies targeting nuclear
hormone receptors.
Besides the NMR vacancy there are 5 more post-doc positions available in
Mölndal:
Nuclear hormone receptor biology, see:
http://vp.astrazeneca.se/hr/show_vacant.asp?ItId=1520
Chemical genetics, see:
http://vp.astrazeneca.se/hr/show_vacant.asp?ItId=1521
Exploratory hit identification, see:
http://vp.astrazeneca.se/hr/show_vacant.asp?ItId=1521
http://vp.astrazeneca.se/hr/show_vacant.asp?ItId=1529
http://vp.astrazeneca.se/hr/show_vacant.asp?ItId=1530
This archive was generated by hypermail 2b29 : Mon Jan 21 2002 - 18:08:05 PST